Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 2 days, and 1 more · Every feed →

All 40Congress 0Executive branch 0Insiders 40
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

INM · $15K+ · 40 trades

Trades
40
Buys 40 · Sells 0
People
6
Stocks
1
Disclosed value
$1.7M
range midpoints · Congress & executive
Filed late
24
  1. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$21.9Kdisclosed Oct 5 · filed 4 days after the trade
  2. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$24.2Kdisclosed Oct 5 · filed the same day
  3. ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$21.9Kdisclosed Oct 5 · filed 4 days after the trade
  4. ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$24.2Kdisclosed Oct 5 · filed the same day
  5. ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$70.4Kdisclosed Sep 16 · filed 1 day after the trade
  6. ▲ BUYDaniel Schneeberger 10% ownerINM InMed Pharmaceuticals Inc.$36.9Kdisclosed Sep 16 · filed 2 days after the trade
  7. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$36.9Kdisclosed Sep 16 · filed 2 days after the trade
  8. ▲ BUYADAR1 Capital Management, LLC 10% ownerINM InMed Pharmaceuticals Inc.$70.4Kdisclosed Sep 16 · filed 1 day after the trade
  9. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$21.3Kdisclosed Jul 16 · filed 1 day after the trade
  10. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$21.3Kdisclosed Jul 16 · filed 1 day after the trade
  11. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$21.3Kdisclosed Jul 16 · filed 1 day after the trade
  12. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$21.3Kdisclosed Jul 16 · filed 1 day after the trade
  13. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$44.9Kdisclosed Jun 10 · filed 2 days after the trade
  14. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$23Kdisclosed Jun 10 · filed 9 days after the trade · late
  15. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$52.2Kdisclosed Jun 10 · filed 20 days after the trade · late
  16. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$23Kdisclosed Jun 10 · filed 9 days after the trade · late
  17. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$31.5Kdisclosed Jun 10 · filed 8 days after the trade · late
  18. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$25.4Kdisclosed Jun 10 · filed 12 days after the trade · late
  19. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$23Kdisclosed Jun 10 · filed 9 days after the trade · late
  20. ▲ BUYVivo Opportunity Fund Holdings, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$44.9Kdisclosed Jun 10 · filed 2 days after the trade
  21. ▲ BUYVivo Opportunity, LLC 10% ownerINM InMed Pharmaceuticals Inc.$79.6Kdisclosed Jun 10 · filed 21 days after the trade · late
  22. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$52.2Kdisclosed Jun 10 · filed 20 days after the trade · late
  23. ▲ BUYVivo Opportunity Cayman Fund, L.P. 10% ownerINM InMed Pharmaceuticals Inc.$25.4Kdisclosed Jun 10 · filed 12 days after the trade · late
  24. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$31.5Kdisclosed Jun 10 · filed 8 days after the trade · late
  25. ▲ BUYVivo Opportunity Cayman, LLC 10% ownerINM InMed Pharmaceuticals Inc.$79.6Kdisclosed Jun 10 · filed 21 days after the trade · late